Skip to main content
Clinical Trials/NCT07263399
NCT07263399
Not yet recruiting
Not Applicable

Effect of Hydrogen Gas on Hyperbaric Oxygen Toxicity - A Randomized Controlled Cross-Over Trial

Blekinge Institute of Technology2 sites in 1 country32 target enrollmentStarted: January 1, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Blekinge Institute of Technology
Enrollment
32
Locations
2
Primary Endpoint
Change in Vital Capacity (ΔVC)

Overview

Brief Summary

The goal of this trial is to investigate whether adding a small fraction of hydrogen gas to an oxygen-enriched breathing mixture can reduce pulmonary oxygen toxicity (POT) in healthy and active divers from the Swedish Armed Forces. The main questions it aims to answer are:

  • Does hydrogen gas reduce oxidative stress and changes in pulmonary function associated with prolonged hyperbaric oxygen exposure?
  • What are the underlying pathophysiological mechanisms of pulmonary oxygen toxicity?

Researchers will compare oxygen-enriched breathing gas with 1-2% hydrogen to oxygen-enriched gas with 1-2% nitrogen (control) to see if hydrogen provides protective effects against POT during hyperbaric exposure.

Participants will:

  • Complete two hyperbaric exposure sessions (hydrogen vs. nitrogen), each lasting 240 minutes at 1.75 ATA
  • Undergo pulmonary function tests and sampling of blod and urin before and after each session
  • Serve as their own controls in a double-blind, randomized, crossover study design

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Military divers actively serving, aged 20-64 years
  • Meeting the Swedish Armed Forces physical standards for diving

Exclusion Criteria

  • Ongoing infection or illness that may impact pulmonary function
  • Use of alcohol or smoking cigarettes within 48 hours
  • Diving with any breathing gas within 48 hours
  • Diving with oxygen-enriched gas (100% O₂) within 2 weeks
  • Use of medications that could affect oxidative stress, lung function, or neurological status
  • Medical history of serious diving-related injuries or long-term complications

Outcomes

Primary Outcomes

Change in Vital Capacity (ΔVC)

Time Frame: Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.

Absolute change in vital capacity (VC), calculated as the difference in liters (L) between pre-exposure and post-exposure spirometry values, measured after each hyperbaric oxygen exposure session.

Secondary Outcomes

  • Forced Expiratory Volume in One Second (FEV₁)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure)
  • Change in FEV₁/FVC ratio(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure)
  • Change in Forced Expiratory Flow 25-75% (FEF25-75%)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Peak Expiratory Flow (PEF)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Inspiratory Capacity (IC)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Total Lung Capacity (TLC)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Residual Volume (Δ RV)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Functional Residual Capacity (Δ FRC)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Diffusing Capacity for Carbon Monoxide (ΔDLCO)(Pre-exposure, 30-120 minutes post-exposure and 24-36 hours post-exposure.)
  • Airway Resistance (Impulse Oscillometry, Tremoflo™)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Index of Oxygen Stress (ΔiOS)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Fractional Exhaled Nitric Oxide (ΔFeNO)(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Change in Exhaled Breath Particle Analysis (ΔPExA)(Pre-exposure and follow-up 24-36 hours post-exposure after each intervention.)
  • Blood and Urinary Biomarkers of Oxidative Stress and Inflammation(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)
  • Biomarkers of Neuronal Injury(Pre-exposure, 30-120 minutes post-exposure, and 24-36 hours post-exposure.)

Investigators

Sponsor
Blekinge Institute of Technology
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials